Stock Price & Analysis

The S1 support level for PACB Stock is $1.12 ,The R1 resistant level for PACB Stock is $1.34.

As of the end of day on 2025-04-02, the price of PACB Stock was $1.165.

The target price for PACB Stock according to analyst rating is 2.20, with the highest price target at 3.50 and the lowest at 1.50. Analysts have a Moderate Buy rating on PACB Stock overall.

The market cap of PACB is $378.3M.

Pacific Biosciences of California, Inc. is a life science technology company. It is engaged in designing, developing, and manufacturing advanced sequencing solutions that enable scientists and clinical researchers to resolve genetically complex problems. Its products and technology under development stem from two differentiated core technologies, which include its HiFi long-read sequencing technology and its Sequencing by Binding (SBB) short-read sequencing technology. Its products address solutions across a set of applications, including human genetics, plant and animal sciences, infectious disease and microbiology, oncology, and other emerging applications. It has developed HiFi long-read sequencing based on Single-Molecule Real-Time technology, which accurately detects the nucleotide sequence and epigenetic status of individual DNA molecules. Its Revio, Sequel, Sequel II and Sequel IIe instruments conduct, monitor, and analyze single-molecule biochemical reactions in real time.

PACB has a total of 796 employees.